Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women's Initiative for Leading at Lilly (WILL). Embed AI capabilities directly into active discovery programs, identify high-value opportunities where computational design can change program outcomes, and establish rigorous measures of impact including novel molecular solutions, hit rates, design precision, experimental efficiency, and advancement of differentiated therapeutic candidates.